发明名称 |
PYRROLO [1,2-C] IMIDAZOLE DERIVATIVES FOR USE IN THE PROPHYLAXIS OR TREATMENT OF CANCER WHICH IS REFRACTORY TO KNOWN CANCER THERAPIES |
摘要 |
The present invention mainly aims to provide a drug for the prophylaxis or treatment of androgen-independent prostate cancer, which is highly useful as a pharmaceutical agent. The present invention provides a drug for the prophylaxis or treatment of androgen-independent prostate cancer, containing a steroid C17,20 lyase inhibitor, particularly, a compound represented by the formula (I):;;wherein n is an integer of 1 to 3, and Ar is an aromatic ring optionally having substituent(s), or a salt thereof or a prodrug thereof. |
申请公布号 |
US2014256693(A1) |
申请公布日期 |
2014.09.11 |
申请号 |
US201414173388 |
申请日期 |
2014.02.05 |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
Yamaoka Masuo;Hara Takahito |
分类号 |
C07D487/04;A61K45/06;A61K31/4188 |
主分类号 |
C07D487/04 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for preventing or treating androgen-independent prostate cancer in a mammal, which comprises administering an effective amount of a steroid C17,20 lyase inhibitor to said mammal. |
地址 |
Osaka-Shi JP |